148
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Differentiating poor validity from probable impairment on the medical symptom validity test: a cross-validation study

, , &
Pages 217-224 | Received 08 Mar 2018, Accepted 15 Sep 2018, Published online: 28 Nov 2018

References

  • Dunham KJ, Denney RL. Development of the poor validity profile analysis for the Medical Symptom Validity Test. Arch Clin Neuropsych. 2016; 31(8): 944–953.
  • Larrabee GJ. Performance validity and symptom validity in neuropsychological assessment. J Inter Neuropsych Soc. 2012; 18(4): 625–631.
  • Bush SS, Ruff RM, Troster AI, et al. Symptom validity assessment: Practice issues and medical necessity, NAN policy and planning committee. Arch Clin Neuropsych. 2005; 20: 419–426.
  • Heilbronner RL, Sweet JJ, Morgan JE, et al. American Academy of Clinical Neuropsychology consensus conference statement on the neuropsychological assessment of effort, response bias, and malingering. Clin Neuropsychol. 2009; 23(7): 1093–1129.
  • Green P. Green’s medical symptom validity test (MSVT) for Microsoft windows: User’s manual. Edmonton, Canada: Green’s Publishing; 2004.
  • Howe LL, Anderson AM, Kaufman DA, et al. Characterization of the Medical Symptom Validity Test in evaluation of clinically referred memory disorders clinic patients. Arch Clin Neuropsych. 2007; 22(6): 753–761.
  • Green P. The advanced interpretation program (version 5.0; released in 2014). Edmonton, Canada: Green’s Publishing; 2008.
  • Slick DJ, Sherman EM, Iverson GL. Diagnostic criteria for malingered neurocognitive dysfunction: proposed standards for clinical practice and research. Clin Neuropsychol. 1999; 13(4): 545–561.
  • Carone DA. Test review of the medical symptom validity test. Appl Neuropsychol. 2009;16(4): 309–311.
  • Howe LL, Loring DW. Classification accuracy and predictive ability of the medical symptom validity test’s dementia profile and general memory impairment profile. Clin Neuropsychol. 2009; 23(2): 329–342.
  • Axelrod BN, Schutte C. Analysis of the dementia profile on the Medical Symptom Validity Test. Clin Neuropsychol. 2010; 24(5): 873–881.
  • Chafetz MD, Biondolillo AM. Feigning a severe impairment profile. Arch Clin Neuropsychol. 2013; 28: 205–212.
  • Singhal A, Green P, Ashaye K, et al. High specificity of the Medical Symptom Validity Test in patients with very severe memory impairment. Arch Clin Neuropsychol . 2009; 24: 721–728.
  • Reslan S, Axelrod BN. Evaluating the Medical Symptom Validity Test (MSVT) in a sample of veterans between the ages of 18 to 64. Appl Neuropsychol Adul. 2016; 1–8.
  • Green P, Allen L, Astner K. Manualized for the computerized Word Memory Test. Durham, NC: Cognisyst; 1996.
  • Armistead-Jehle P, Denney RL. The detection of feigned impairment using the WMT, MSVT, and NV-MSVT. Appl Neuropsychol Adult. 2014; 22: 147–155.
  • Axelrod BN, Schutte C. Concurrent validity of three forced-choice measures of symptom validity. Appl Neuropsychol. 2011; 18: 27–33.
  • Tombaugh TN. The test of memory malingering. Los Angeles, CA: Western Psychology Corporation; 1996.
  • Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test Second edition, adult version. San Antonio: TX: The Psychological Corporation; 2000.
  • The Psychological Corporation. Wechsler Adult Intelligence Scale, Fourth Edition manual. San Antonio: TX: Author; 2008.
  • Heaton RK, Miller SW, Taylor MJ, et al. Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources, Inc.; 2004.
  • Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical applications; with a supplement for the Wechsler Adult Intelligence Scale-Revised (WAIS-R). Psychol Assess Resour. 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.